Abhishek Garg: Excellent commentary on our recent study on innovative dendritic cell vaccines and how to overcome unanticipated resistance
Abhishek Garg, Head of the Laboratory of Cell Stress and Immunity (CSI) at KU Leuven, recently shared on LinkedIn:
“Thanks, Kepp Oliver, Guido Kroemer, and team for this excellent commentary on our recent study on innovative dendritic cell vaccines and how to overcome unanticipated resistance pathways against them in immunotherapy-resistant immune-cold tumors! Led by Jenny Sprooten in our lab!
A clinical trial based on these insights is currently in process of being initiated via our GLIOMATCH collaboration with Rüdiger Sorg and Angeliki Datsi for glioblastoma patients, powered by European Commission and Horizon Europe mission cancer grant!
Read their onco-immunology commentary at Taylor and Francis Group here.
Read the original research in Cell Press Elsevier.”
Source: Abhishek Garg/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023